Angelo de Mattos, M.D., M.P.H.

Angelo de Mattos, M.D., M.P.H.

Specialties

Internal Medicine

Nephrology

Surgery - Transplant

Department

Internal Medicine

Title

  • Professor
  • Chief of Transplant Nephrology
  • Medical Director of Kidney Pancreas Transplant Medicine
To see if Angelo de Mattos is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).

UC Davis Medical Center

2221 Stockton Blvd., Suite B
Sacramento, CA 95817
Driving Directions

Primary Phone:
916-734-2111

Additional Phone Numbers

Phone: (916) 734-1516 (Assistant)
Physician Referrals: 800-4-UCDAVIS (800-482-3284)

Philosophy of Care

Coinciding with the mission of the Department of Internal Medicine, my goal is to provide excellence in clinical care, research and education, and to deliver high-quality medical care with commitment to cutting-edge research and superior physician training.

Clinical Interests

My clinical interests focus on kidney and kidney-pancreas transplantation and Nephrology. My research focuses on seeking a better understanding of cardiovascular disease in individuals with chronic kidney disease and approaches to early detection and intervention. I am also interested in renal transplantation access, outcomes research, and recurrence of renal disease after transplantation.

Division

Transplant Nephrology

Center/Program Affiliation

Transplant Center

Education

M.D., Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil, 1985

M.P.H., Oregon State University, Portland OR 2004

Residency

Hospital dos Servidores do Rio de Janeiro, Rio de Janeiro, Brazil, 1989

University of Miami Jackson Memorial Medical Center, Miami FL 1992

Fellowships

Oregon Health & Science University, Portland OR 1994

Board Certifications

American Board of Internal Medicine, 2004

American Board of Internal Medicine, Nephrology, 2008

Professional Memberships

American College of Physicians

American Society of Nephrology

International Society of Nephrology

Jefferson County Medical Society

National Kidney Foundation

Honors and Awards

Nephrology Best Abstract Award, 2006

National Kidney Foundation of Oregon & Washington, 2000

Physician of the Year, 1999

Select Recent Publications

Rajesh Venkataraman, Fadi G. Hage, Todd A. Dorfman, Jaekyeong Heo, Raed A. Aqel, Angelo M. de Mattos, Ami E. Iskandrian. Relation between Heart Rate Response to Adenosine and Mortality in Patients with End-Stage Renal Disease. American Journal of Cardiology 103: 1159-1164, 2009.

Rajesh Venkataraman, Fadi G. Hage, Todd Dorfman, Jaekyeong Heo, Raed A. Aqel, Angelo M. de Mattos, Ami E. Iskandrian. Role of Myocardial Perfusion Imaging in Patients with End-Stage Renal Disease Undergoing Coronary Angiography. American Journal of Cardiology 102: 1451-1456, 2008.

S. L. Kasiske, A. de Mattos, S. M. Flechner, L. Gallon, H.-U. Meier-Kriesche, M. R. Weir and A. Wilkinson. Mammalian Target of Rapamycin Inhibitor Dyslipidemia in Kidney Transplant Recipients. American Journal of Transplantation, Volume 8, Issue 7, Pages 1384-1392, 2008.

de Mattos AM, Siedlecki A, Gaston RS, Perry GJ, Julian SA, Kew CE 2nd, Deierhoi MH, Young C, Curtis JJ, Iskandrian AE. Systolic Dysfunction Portends Increased Mortality among Those Waiting for Renal Transplant. Journal of the American Society of Nephrology, 19: 1191-1196, 2008.

Miha Arnol, Angelo M. de Mattos, Jae S. Chung, Jonathan C. Prather, Anuja Mittalhenkle, Douglas J. Norman. Late Steroid Withdrawal and Cardiovascular Events in Kidney Transplant Recipients. Transplantation 86 (12):1844-1848, 2008.

Hage FG, Smalheiser S, Zoghbi GJ, Perry GJ, Deierhoi M, Warnock D, Iskandrian AE, de Mattos AM, Aqel RA. Predictors of Survival in Patients with End Stage Renal Disease Evaluated for Kidney Transplantation. American Journal of Cardiology, 100(6): 1020-1025, 2007

Andrew Siedlecki, Margaret Foushee, John J. Curtis, Robert S. Gaston, Gilbert Perry, Ami E. Iskandrian, Angelo M. de Mattos. The Impact of Left Ventricular Systolic Dysfunction on Survival after Renal Transplantation. Transplantation, 84:1610-1617, 2007.

Chandrakantan A, de Mattos A, Naftel D, Crosswy A, Kirklin J, Curtis J. Increasing referral for end-stage renal disease in prior extrarenal solid organ transplant recipients at a single center. Clinical Journal of American Society of Nephrology 1 (4): 832-836, 2006.

de Mattos A, Prather J, Olyaei A, Shibagaki Y, Keith D, Mori M, Norman D, Becker T. Cardiovascular Events Following Renal Transplantation: Role of Traditional and Transplant Specific Risk Factors. Kidney International 70 (4), 757?764, 2006.

de Mattos AM, Olyaei AJ, Prather JC, Golconda MS, Barry JM, and Norman DJ. Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation. Kidney International, 67: 714 - 720, 2005.

Hippen BE, de Mattos AM, Cook WJ, Kew CE, Gaston RS. CD20-positive infiltrates predict steroid-resistance and reduced renal allograft survival in acute cellular rejection. American Journal of Transplantation 5: 2248-2252, 2005.

Keith DS, de Mattos AM, Golconda M, Prather J, Cantarovich M, Paraskevas S, Tchervenkov J, Norman DJ. Factors Associated with Improvement in Deceased Donor Renal Allograft Function in the 1990s. Journal of the American Society of Nephrology, 16: 1512-1521, 2005

Taylor GS, Prather JC, Norman DJ, deMattos AM, Moglishetty G, Conlin MJ, Barry JM. Living unrelated donor renal transplantation: a single center experience. The Journal of Urology, 174: 223-225, 2005.

Olyaei AJ, de Mattos AM, Bennett WM. Cardiovascular complications of immunosuppressive agents in renal transplant recipients. Expert Opinion on Drug Safety, 4(1):29-44, 2005.

Olyaei, AJ, de Mattos AM, Bennett, WM. Cardiovascular Disease in Kidney Transplant Recipients: Are Patients Truly Stable? Graft, 7 (3): 136-155, 2005.